Fever News and Research

RSS

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

10 Mar 2011

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.

9 Mar 2011

Study reveals expansion of NK cells after acute infection

The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass.

3 Mar 2011

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

Eisai announced today that results from the global Phase III clinical study "EMBRACE" will be published online in The Lancet.

3 Mar 2011

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

While lab tests and imaging can sometimes help diagnose juvenile idiopathic arthritis (JIA), a physical examination and thorough patient history are the most valuable tools in identifying this disease. According to a new literature review from the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the rate of false positives in laboratory evaluations and imaging studies meant to screen for juvenile arthritis makes their value limited.

3 Mar 2011

Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007

Over the past decade, drug-related poisonings have been on the rise in the United States. In fact, in many states drug-related poisoning deaths have now surpassed motor vehicle crash fatalities to become the leading cause of injury death. While the fatalities from this epidemic have been well reported, they are only the tip of the iceberg.

2 Mar 2011

Depression negatively impacts outcomes of care in patients with CRS: New research

Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2011

Treat discomfort not fever say the new pediatric guidelines

According to a new report from the American Academy of Pediatrics (AAP), fevers alone are not a cause for intervention in children. Dr. Janice Sullivan, the lead author of the report says, “The focus should be on comfort and not on absolute temperature.” That’s because fever can be help fight illness, by slowing down the reproduction of bacteria and viruses or stimulating the body’s immune response she explains. “That’s a benefit of fever…and may shorten the time that your child remains ill,” she adds.

28 Feb 2011

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Immune Network Ltd. advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2nd to 5th March, 2011.

28 Feb 2011

Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma

Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.

28 Feb 2011

Authorities work to contain measles scare

Health authorities are trying to prevent an outbreak of measles after a woman carrying the transmissible infection travelled widely throughout the United States. The lady in question, 27, allegedly contracted the airborne virus in the United Kingdom and arrived in the United States last week, passing through three U.S. airports on her way to New Mexico, where she is believed to reside. She arrived at Washington Dulles International Airport on Tuesday, February 22, from London.

28 Feb 2011

Experts offer myth-busting advice to fight against spring allergies

Millions of Americans sneeze and wheeze March through June when they use misinformation to manage their spring allergies.

27 Feb 2011

Most patients 'want to be listened, informed and considered by family doctor'

A study conducted at the University of Granada reveals that patients have greater expectations of their family doctor listening actively to them, keeping them informed and considering their opinions than in getting involved in decision making. For the purpose of this study, researchers took a sample of 360 patients aged 16-47 years, assisted at the Health Center Gran Capitán in Granada

25 Feb 2011

Transgenic fungal approach can fight against malaria and bug-borne diseases

New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining.

24 Feb 2011

Finally! A vaccine against Dengue

Scientists from Thailand have successfully produced the world’s first dengue hemorrhagic fever vaccine and will allow the private sector improve it for the effective treatment of patients. The Thailand Ministry of Science and Technology has introduced the world’s first live attenuated dengue hemorrhagic fever vaccine.

23 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Murray valley encephalitis surfaces after 37 years

A fatal and severe form of mosquito borne viral brain infection has been detected in the Riverina Murray region of New South Wales. Murray Valley encephalitis has affected sentinel chicken flocks in the northern Victorian towns of Mildura, Robinvale, Kerang and Barmah as well in the New South Wales town of Tooleybuc, near Swan Hill. The virus has not been diagnosed in a Victorian for 37 years said Victoria’s Chief Health Officer Dr John Carnie. He said although the virus had not been detected in a human, Victorians living along the Murray River should avoid being bitten by mosquitoes.

22 Feb 2011

Experimental vaccine appears to protect against pneumonia

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.

22 Feb 2011

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.

21 Feb 2011

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

When it comes to curing skin infected with the antibiotic-resistant bacterium MRSA, timely and proper wound cleaning and draining may be more important than the choice of antibiotic, according to a new Johns Hopkins Children's Center study. The work is published in the March issue of Pediatrics.

21 Feb 2011

Fever News and Research

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

Study reveals expansion of NK cells after acute infection

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007

Depression negatively impacts outcomes of care in patients with CRS: New research

Treat discomfort not fever say the new pediatric guidelines

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma

Authorities work to contain measles scare

Experts offer myth-busting advice to fight against spring allergies

Most patients 'want to be listened, informed and considered by family doctor'

Transgenic fungal approach can fight against malaria and bug-borne diseases

Finally! A vaccine against Dengue

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Murray valley encephalitis surfaces after 37 years

Experimental vaccine appears to protect against pneumonia

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News